Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)

China flag China · Delayed Price · Currency is CNY
11.18
-0.10 (-0.89%)
At close: Feb 13, 2026
Market Cap1.97B +13.4%
Revenue (ttm)244.84M -19.5%
Net Income-69.85M
EPS-0.40
Shares Out176.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,656,110
Average Volume2,806,194
Open11.26
Previous Close11.28
Day's Range10.86 - 11.48
52-Week Range5.77 - 17.49
Beta0.25
RSI31.54
Earnings DateApr 27, 2026

About SHE:002898

Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pantoprazole sodium products, etc. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proto... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 514
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002898
Full Company Profile

Financial Performance

Financial Statements